We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Par Bolsters Generic Drug Pipeline With $410 Million Deal for Anchen
Par Bolsters Generic Drug Pipeline With $410 Million Deal for Anchen
August 30, 2011
Par Pharmaceutical is expanding its generic-drug portfolio with the $410 million purchase of Anchen Pharmaceuticals it hopes to finalize by the end of the year.